SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 26.02+1.2%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (7512)4/24/1999 11:58:00 AM
From: BigKNY3  Read Replies (1) of 9523
 
"S&P Still Upbeat on Drug Stocks" personalwealth.com

S&P equity analyst Herman Saftlas remains positive on major pharmaceutical firms as their stocks have rallied in response to good first quarter results. He says fundamentals for the drug industry remain strong, and he expects the group to maintain mid-to-high double-digit EPS growth going forward, led by new drugs, direct to consumer advertising, and expansion in pharmacy benefit plans. His favorites stocks in the group are Pfizer Inc. (NYSE:PFE), Schering-Plough (NYSE:SGP), and Bristol-Myers Squibb (NYSE:BMY), all rated 5 STARS (buy).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext